Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Exercise matters for neuroendocrine tumor patients. A new study found that NET patients with lower physical activity levels experience significantly more fatigue and worse quality of life than their more active counterparts. Researchers say the findings make a strong case for structured exercise programs tailored to this often-overlooked patient group.
For patients living with neuroendocrine tumors (NETs), staying physically active could be a game-changer. A study presented at the 2026 NANETS Multidisciplinary NET Medical Symposium found that lower physical activity levels were strongly linked to greater fatigue and poorer quality-of-life outcomes — while more active patients reported better social and sexual functioning.
The retrospective, cross-sectional analysis included 95 NET patients seen at the Huntsman Cancer Institute in Salt Lake City between January and March 2026. The majority had distant metastases, and over half were classified as underactive based on the Rapid Assessment of Physical Activity (RAPA) tool.
Researchers noted that, unlike many other solid tumor types, the role of exercise in NET patients has been poorly studied — making this one of the first comprehensive assessments of its kind. A prospective study is already in development at the institution.
By the Numbers:
Why it matters: With fatigue being one of the most debilitating symptoms for cancer patients, identifying modifiable factors like physical activity could meaningfully improve daily life for NET patients — and opens the door for evidence-based exercise prescriptions in this population.
